| 000 | 00970 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250511153544.0 | ||
| 264 | 0 | _c19770622 | |
| 008 | 197706s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/BF00606410 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnderman, B | |
| 245 | 0 | 0 |
_aClozapine-induced agranulocytosis: a situation report up to August 1976. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cMar 1977 |
||
| 300 |
_a199-201 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAgranulocytosis _xchemically induced |
| 650 | 0 | 4 |
_aClozapine _xadverse effects |
| 650 | 0 | 4 |
_aDibenzazepines _xadverse effects |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFinland |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aGriffith, R W | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 11 _gno. 3 _gp. 199-201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00606410 _zAvailable from publisher's website |
| 999 |
_c860060 _d860060 |
||